coteauBeta Get App

COR

Cencora
$338.48
-0.57% Oct 22 close
Health CareS&P 500 CompareTechnicals
-23%-13%-3%+7%+17%Oct 2025Oct 2026Apr 202652w high $372.5352w low $251.67
CORSPY
1W
-0.9%
1M
+7.6%
3M
+11.2%
6M
+9.2%
YTD
+0.8%
1Y
+3.1%

Live chart

Loading live chart…

What they do

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services.

Healthcare · Medical Distribution

For information only · Important disclosures

Grades vs sector

Momentum
22nd percentile in sector
D
12-1 return: -10.4%
Percentile within its GICS sector across the S&P 1500.
Growth
27th percentile in sector
D+
Revenue growth (YoY): +5.1%
Percentile within its GICS sector across the S&P 1500.
Value
59th percentile in sector
B-
Forward E/P: 5.8% · EBITDA/EV: 7.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
60th percentile in sector
B-
Profit margin: +0.8% · Return on equity: +96.9%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
ranked 291 of 499 · 12-month momentum 4.3%
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
Cencora (COR) files 8-K: results, Reg FD disclosure
SEC 8-K · Oct 21
26 ETFs Add to Cencora (COR) Holdings on Oct. 16
GuruFocus.com · Oct 20

Key stats

52-week range$251.67 – $372.53
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

Earnings

Next report: 2026-11-04 · before open · EPS est 4.57
24-1125-0225-0525-0825-1126-0226-0526-080.004.75
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-054.344.48+3.2%
2026-05-064.734.75+0.5%
2026-02-044.044.08+1.0%
2025-11-053.793.84+1.4%
2025-08-063.844.00+4.2%
2025-05-074.104.42+7.9%
2025-02-053.523.73+6.0%
2024-11-063.233.34+3.5%
Insider trades
Krikorian Lazarus
SVP & Chief Accounting Officer · 2026-10-01
Sell
$298.9K
Greenberg Lon R
Director · 2026-09-16
Sell
$411.3K
Krikorian Lazarus
SVP & Chief Accounting Officer · 2026-09-01
Sell
$321.1K
Campbell Elizabeth S
Executive Vice President · 2026-08-24
Sell
$3.7M
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-21 18:18:27 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Free to use. No card, no ads, no auto-renew.

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Beta 0.9 · Oct 21, 2026